Skip to content

AARD AARD Other Non-Current Assets

Other Non-Current Assets at other companies

Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$19.5K-11.3%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$2.64M-37.5%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$61M-14.1%
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's other non-current assets?
AARD (AARD) reported other non-current assets of $4.74M in Q1 2026.
How has AARD's other non-current assets changed year-over-year?
AARD's other non-current assets increased by 157.2% year-over-year, from $1.84M to $4.74M.
What does other non-current assets mean?
This category captures long-term assets that do not fit into standard classifications like property, plant, equipment, or intangible assets. It may include long-term deposits, deferred tax assets, or other miscellaneous non-current investments. It represents the residual value of long-term resources held by the company.